Symbol="RCKT"
AssetType="Common Stock"
Name="Rocket Pharmaceuticals Inc"
Description="Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey."
CIK="1281895"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1278745000"
EBITDA="-253559008"
PERatio="None"
PEGRatio="None"
BookValue="5.0"
DividendPerShare="0"
DividendYield="0"
EPS="-3.16"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.361"
ReturnOnEquityTTM="-0.629"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="52.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.072"
EVToRevenue="-"
EVToEBITDA="-6.39"
Beta="1.153"
num_52WeekHigh="24.53"
num_52WeekLow="11.78"
num_50DayMovingAverage="18.86"
num_200DayMovingAverage="19.34"
SharesOutstanding="80526000"
DividendDate="2018-01-05"
ExDividendDate="None"
symbol="RCKT"
open="15.91"
high="16.19"
low="15.83"
price="15.86"
volume="338349.00"
latest_trading_day="2023-08-23"
previous_close="15.88"
change="-0.02"
change_percent="-0.1259%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="45"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="673425"
Change_recent_avg="-0.02"
Delta_recent_avg="0.87"
Variance_recent_avg="0.43"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="1142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_negative_thumbnail_id_2="102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_neutral_thumbnail_id_1="561"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="599"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_positive_thumbnail_id_2="633"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
